$300 Million is the total value of Decheng Capital Management III (Cayman), LLC's 26 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 900.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ALPN | New | Alpine Immune Sciences, Inc. | $76,809,898 | – | 6,708,288 | +100.0% | 25.63% | – |
| Buy | Aura Biosciences, Inc. | $18,243,928 | +403.6% | 1,163,123 | +296.5% | 6.09% | +436.0% | |
| New | ROIVANT SCIENCES LTD | $17,049,296 | – | 1,459,700 | +100.0% | 5.69% | – | |
| LNTH | New | LANTHEUS HOLDINGS INC(NMS) | $9,879,778 | – | 142,196 | +100.0% | 3.30% | – |
| IMGN | New | IMMUNOGEN INC | $6,600,016 | – | 415,880 | +100.0% | 2.20% | – |
| SGEN | New | SEAGEN INC | $4,882,420 | – | 23,014 | +100.0% | 1.63% | – |
| BYSI | New | BeyondSpring Inc. | $3,966,514 | – | 4,958,143 | +100.0% | 1.32% | – |
| ATRC | New | AtriCure Inc. | $2,026,144 | – | 46,259 | +100.0% | 0.68% | – |
| New | Pyxis Oncology, Inc (formerly Apexigen) | $650,352 | – | 326,810 | +100.0% | 0.22% | – | |
| New | GeneDx Holdings Corp. | $377,118 | – | 103,604 | +100.0% | 0.13% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2023-12-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Illumnia, Inc. | 7 | Q3 2023 | 16.5% |
| Cue Health Inc. | 7 | Q3 2023 | 17.8% |
| Arcus BioSciences, Inc. | 7 | Q3 2023 | 8.4% |
| 10x Genomics, Inc. | 7 | Q3 2023 | 8.1% |
| Pacific Biosciences of California, Inc. | 7 | Q3 2023 | 6.8% |
| Equillium Inc. | 7 | Q3 2023 | 4.3% |
| Aadi Bioscience, Inc. | 7 | Q3 2023 | 2.7% |
| Adicet Bio, Inc. | 7 | Q3 2023 | 3.6% |
| Aura Biosciences, Inc. | 7 | Q3 2023 | 6.1% |
| Terns Pharmaceuticals, Inc. | 7 | Q3 2023 | 3.4% |
View Decheng Capital Management III (Cayman), LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-01-22 |
| 13F-HR/A | 2023-12-12 |
| 13F-HR/A | 2023-11-29 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-07-28 |
| 13F-HR | 2023-05-10 |
| 13F-HR | 2023-02-09 |
| 13F-HR | 2022-11-08 |
| 4 | 2022-09-27 |
| 13F-HR | 2022-08-01 |
View Decheng Capital Management III (Cayman), LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.